May 11, 2023
The U.S. Drug Enforcement Administration (DEA) is extending the ability for physicians to prescribe controlled substances based on telehealth visits through November 11, 2023. This method had been set to expire when the COVID-19 Public Health Emergency ended today (May 11).
On March 1, the DEA and the Department of Health and Human Services (HHS), sent out notices of proposed rulemakings (NPRMs) to generate feedback on proposals to continue allowing the prescribing of controlled medications via virtual visits with patients. More than 38,000 public comments came in.
“These medications, including those used to treat opioid use disorder, are a vital form of care for millions of Americans who have come to rely on safe and effective telemedicine appointments,” said the AMA in a statement. “Patients being treated with these medications often have challenges securing and traveling to in-person appointments.”
August 28, 2025
The apparent removal of the Centers for Disease Control and Prevention (CDC) Director, Susan Monarez, PhD, after just weeks on the job, further imperils the work of the CDC and the health of Americans. Her removal was followed by the resignations of other senior leaders at the CDC, who have accused HHS Secretary Robert F. Kennedy, Jr. of undermining scientific recommendations for vaccines.
August 26, 2025
University of Minnesota President Rebecca Cunningham, MD, will speak at the Empowering Physicians: A Night of Learning & Connection event on Friday, September 26, from 4 to 9 pm, at the historic Hewing Hotel in downtown Minneapolis.
August 26, 2025
America's physicians are seeing a rise in misinformation and disinformation from patients these days, and it’s impacting patient care, according to a new study from the Physicians Foundation.